We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Safety of rituximab in a patient with chronic renal failure and low-grade non-Hodgkin lymphoma.
- Authors
Chebib, Ralph; Ghorra, Claude; Kattan, Joseph
- Abstract
An 82-year-old man, with known chronic renal failure and a creatinine clearance (CrCl) of 18 mL/min, was diagnosed with low-grade marginal zone non-Hodgkinlymphoma (NHL) of his right orbit. He received rituximab as single treatment (375 mg/m 2 every 3 weeks). After eight cycles, almost complete response was obtained, rituximab was extremely well-tolerated, and his creatinine levels remained stable throughout the whole treatment.
- Subjects
RITUXIMAB; MEDICATION safety; CHRONIC kidney failure; LYMPHOMA diagnosis; LYMPHOMA treatment; CREATININE; PATIENTS
- Publication
Journal of Cancer Research & Therapeutics, 2015, Vol 11, Issue 3, p646
- ISSN
0973-1482
- Publication type
case study
- DOI
10.4103/0973-1482.148677